The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma.

导出 OA

翻译打印收藏纠错

作者： Jędrzej,Borowczak ^[1] ; Krzysztof,Szczerbowski ^[2] ; Mateusz,Maniewski ^[2] ; Marek,Zdrenka ^[3] ; Piotr,Słupski ^[4] ; Hanna,Andrusewicz ^[3] ; Joanna,Łysik-Miśkurka ^[3] ; Paula,Rutkiewicz ^[5] ; Magdalena,Bodnar ^[2] ; Łukasz,Szylberg ^[5]

作者单位： Department of Obstetrics, Gynaecology and Oncology, Chair of Pathomorphology and Clinical Placentology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, University Hospital No. 2 in Bydgoszcz, Ujejskiego 75, 85-168, Bydgoszcz, Poland. jedrzej.borowczak@gmail.com. ^[1] Department of Obstetrics, Gynaecology and Oncology, Chair of Pathomorphology and Clinical Placentology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, University Hospital No. 2 in Bydgoszcz, Ujejskiego 75, 85-168, Bydgoszcz, Poland. ^[2] Department of Tumor Pathology and Pathomorphology, Oncology Centre-Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland. ^[3] Department of Urology, University Hospital No. 2 im. Dr. Jan Biziel in Bydgoszcz, Bydgoszcz, Poland. ^[4] Chair of Pathology, University Hospital No. 2 im. Dr. Jan Biziel in Bydgoszcz, Bydgoszcz, Poland. ^[5]

关键词 Bladder cancer CDK9 Expression P53 Prognosis

主题词人类(Humans);癌, 移行细胞(Carcinoma, Transitional Cell);膀胱肿瘤(Urinary Bladder Neoplasms);预后(Prognosis);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53);细胞周期蛋白依赖激酶9(Cyclin-Dependent Kinase 9)

DOI 10.1007/s12094-022-02994-6

PMID 36374405

发布时间 2023-02-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交